pharma · Scabies · Bioequivalence trial in healthy volunteers
Alphapharm
Alphapharm Pty Ltd
Alphapharm patent portfolio — 12 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU
- Founded
- 1982
- Employees
- 187
- Programs
- 30
- Drugs
- 235
- Patents
- 12
Alphapharm patents
12 pharmaceutical patents indexed for Alphapharm. 4 expire within 24 months.
Alphapharm has 12 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 4 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
CA 2767560
ATOVAQUONE A DIAMETRE DE PARTICULES (D<SB>90</SB>) VARIANT DE PLUS DE 3UM A ENVIRON 10UM
granted -
CA 2765866
FORMULATION PHARMACEUTIQUE
granted -
CA 2712282
COMPOSITION PHARMACEUTIQUE DE DULOXETINE A LIBERATION RETARDEE
granted -
CA 2702664
FORMULATION PHARMACEUTIQUE A LIBERATION CONTROLEE
granted -
WO 2009026621
COMPOSÉ ET COMPOSITION PHARMACEUTIQUES
granted -
CA 2677623
FORME PHARMACEUTIQUE CONTENANT DEUX OU DAVANTAGE DE PRINCIPES ACTIFS PHARMACEUTIQUES SOUS DES FORMES PHYSIQUES DIFFERENTES
granted -
CA 2673419
COMPOSITION PHARMACEUTIQUE
granted -
CA 2673418
COMPOSE ET COMPOSITION PHARMACEUTIQUES
granted -
CA 2653382
COMPOSITION STABILISEE COMPRENANT DES INHIBITEURS DE L'ECA
granted -
AU 2007242062
Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns
granted -
CA 2648495
FORMULATIONS A LIBERATION CONTROLEE QUI COMPRENNENT UNE OU PLUSIEURS UNITES DISCRETES NON ENROBEES ET UNE MATRICE A LIBERATION RETARDEE
granted -
CA 2628716
PROCESSUS DE REGULATION DE LA DIMENSION DE PARTICULE
granted
Frequently asked questions
How many patents does Alphapharm have?
12 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Alphapharm patents expire?
4 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.